11 April 2017 : Original article
Application of Indocyanine Green (ICG) Detection in Evaluating Early Prognosis in Patients with Fatty Liver Disease After Liver Transplantation
DOI: 10.12659/AOT.901277
Ann Transplant 2017; 22:208-214
Related articles
28 Jun 2020 : Database Analysis
Key genes associated with non-alcoholic fatty liver disease and acute myocardial infarction
Weiran Dai, Yue Sun
DOI: 10.12659/MSM.922492
Med Sci Monit 2020; 26:e922492
16 Aug 2019 : Original article
Analysis of Data from the Oxygen Persufflation in Liver Transplantation (OPAL) Study to Determine the Role of Factors Affecting the Hepatic Microcirculation and Early Allograft Dysfunction
Tamas Benkö, Jennifer Belker
DOI: 10.12659/AOT.915214
Ann Transplant 2019; 24:481-488
26 Nov 2018 : Animal Research
The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN)
Jianlong Gao, Rui Xiong
DOI: 10.12659/MSM.910544
Med Sci Monit 2018; 24: ANS8533-8543
08 Aug 2014 : Original article
Thiazolidinedione Therapy Versus Lifestyle Recommendation in the Treatment of Post-Liver Transplant Graft Steatosis
Fredrik Åberg, Virve Koljonen
DOI: 10.12659/AOT.890664
Ann Transplant 2014; 19:389-396
01 Aug 2010
A newly-designed positioning system for simultaneous indocyanine green and fluorescein anterior segment angiography of the albino rabbit
Jianguo Wu, Xiaoxu Zhou
Med Sci Monit 2010; 16(8): BR246-249
01 Jun 2018 : Clinical Research
Predictive Value of Indocyanine Green Plasma Disappearance Rate on Liver Function and Complications After Liver Transplantation
Yan Sun, Lixin Yu
DOI: 10.12659/MSM.907783
Med Sci Monit 2018; 24: CLR3661-3669
17 Jul 2018 : Original article
Graft Regeneration and Functional Recovery in Patients with Early Allograft Dysfunction After Living-Donor Liver Transplantation
Min Suk Chae, Youngchan Kim
DOI: 10.12659/AOT.909112
Ann Transplant 2018; 23:481-490
16 May 2017 : Laboratory Research
MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR)
Xianchao An, Zonglin Yang
DOI: 10.12659/MSM.901377
Med Sci Monit 2017; 23:2299-2307
19 Oct 2016 : Clinical Research
Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1
Ran Ao, Ying Wang
DOI: 10.12659/MSM.897207
Med Sci Monit 2016; 22:3804-3819
02 Nov 2016 : Clinical Research
Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients
Yanjin Hu, Jia Liu
DOI: 10.12659/MSM.897924
Med Sci Monit 2016; 22:4146-4151
29 Aug 2014 : Original article
Deterioration of Heart Rate Recovery Index in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Olcay Ozveren, Orhan Dogdu
DOI: 10.12659/MSM.890741
Med Sci Monit 2014; 20:1539-1543
16 Dec 2013 : Original article
Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes
Aleksandra Trojak, Małgorzata Waluś-Miarka
DOI: 10.12659/MSM.889649
Med Sci Monit 2013; 19:1167-1172
01 Dec 2012
The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
Halina Cichoż-Lach, Krzysztof Celiński
DOI: 10.12659/MSM.883601
Med Sci Monit 2012; 18(12): CR735-740
23 Apr 2012
The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania
Jonas Valantinas, Daiva Asta Apanaviciene
DOI: 10.12659/MSM.882722
Med Sci Monit 2012; 18(5): PH57-62
24 Apr 2011
SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
Yasar Colak, Oguzhan Ozturk
DOI: 10.12659/MSM.881749
Med Sci Monit 2011; 17(5): HY5-9
01 Dec 2009
Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease
Tatjana Abel, Janos Feher
Med Sci Monit 2009; 15(12): MS6-11
30 Mar 2009
Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease
Yusuf Yilmaz, Ozlen Atug
Med Sci Monit 2009; 15(4): HY1-5
25 Sep 2009
Clinical effectiveness of ezetimibe for a non-obese patient with nonalcoholic fatty liver disease
Munechika Enjoji, Masatake Tanaka
Am J Case Rep 2009; 10:145-148
22 Dec 2005
Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.
Daad H. Akbar, Abeer H. Kawther
Med Sci Monit 2006; 12(1): RA23-26
In Press
02 Jun 2023 : Original article
Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria a...Ann Transplant In Press; DOI: 10.12659/AOT.939890
17 May 2023 : Original article
Results of Liver Retransplantation After Rescue Hepatectomy: A Single-Center StudyAnn Transplant In Press; DOI: 10.12659/AOT.939557
10 May 2023 : Original article
Incidence of Thromboembolic Complications Following Kidney Transplantation with Short and Extended Aspirin ...Ann Transplant In Press; DOI: 10.12659/AOT.939143
Most Viewed Current Articles
24 Aug 2021 : Review article
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860